213 related articles for article (PubMed ID: 32844348)
1. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint.
Karadag Soylu N
J Gastrointest Cancer; 2020 Dec; 51(4):1176-1186. PubMed ID: 32844348
[TBL] [Abstract][Full Text] [Related]
2. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.
Rastogi A
World J Gastroenterol; 2018 Sep; 24(35):4000-4013. PubMed ID: 30254404
[TBL] [Abstract][Full Text] [Related]
3. Radiomics in Hepatocellular Carcinoma.
Sagir Kahraman A
J Gastrointest Cancer; 2020 Dec; 51(4):1165-1168. PubMed ID: 32844349
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma.
Samdanci ET; Akatli AN; Soylu NK
J Gastrointest Cancer; 2020 Dec; 51(4):1187-1192. PubMed ID: 32860202
[TBL] [Abstract][Full Text] [Related]
5. HCC and Tumor Biomarkers: Does One Size Fits All?
Ozgor D; Otan E
J Gastrointest Cancer; 2020 Dec; 51(4):1122-1126. PubMed ID: 32827068
[TBL] [Abstract][Full Text] [Related]
6. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
[TBL] [Abstract][Full Text] [Related]
7. Tumor Diameter for Hepatocellular Carcinoma: Why Should Size Matter?
Usta S; Kayaalp C
J Gastrointest Cancer; 2020 Dec; 51(4):1114-1117. PubMed ID: 32851543
[TBL] [Abstract][Full Text] [Related]
8. Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma.
Sciarra A; Park YN; Sempoux C
Hum Pathol; 2020 Feb; 96():48-55. PubMed ID: 31931021
[TBL] [Abstract][Full Text] [Related]
9. Microvascular Venous Invasion in Hepatocellular Carcinoma: Why Do Recurrences Occur?
Isik B; Gonultas F; Sahin T; Yilmaz S
J Gastrointest Cancer; 2020 Dec; 51(4):1133-1136. PubMed ID: 32839943
[TBL] [Abstract][Full Text] [Related]
10. Malatya and Other Criteria for Liver Transplantation in Hepatocellular Carcinoma.
Ince V; Ara C; Yilmaz S
J Gastrointest Cancer; 2020 Dec; 51(4):1118-1121. PubMed ID: 32860615
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma.
Maimaitiming A; Zhou X; Ma X; Huang Y; Wang Q; Deng R; Ren Y; Chai X; Zhang P
J Invest Surg; 2020 Jul; 33(6):536-541. PubMed ID: 30543135
[No Abstract] [Full Text] [Related]
12. Pan-cancer analysis identifies
Chang QH; Mao T; Tao Y; Dong T; Tang XX; Ge GH; Xu ZJ
Aging (Albany NY); 2021 Mar; 13(8):11096-11119. PubMed ID: 33744857
[TBL] [Abstract][Full Text] [Related]
13. Update on Ancillary Testing in the Evaluation of High-Grade Liver Tumors.
Koehne de Gonzalez A; Lagana SM
Surg Pathol Clin; 2018 Jun; 11(2):367-375. PubMed ID: 29751880
[TBL] [Abstract][Full Text] [Related]
14. HN1 as a diagnostic and prognostic biomarker for liver cancer.
Liu Z; Yang D; Li Y; Jiao Y; Lv G
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32700728
[TBL] [Abstract][Full Text] [Related]
15. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review.
Kopystecka A; Patryn R; Leśniewska M; Budzyńska J; Kozioł I
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298294
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.
Wee A
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):266-72. PubMed ID: 16932016
[TBL] [Abstract][Full Text] [Related]
17. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.
Zhong CQ; Zhang XP; Ma N; Zhang EB; Li JJ; Jiang YB; Gao YZ; Yuan YM; Lan SQ; Xie D; Cheng SQ
Cancer Med; 2018 Jun; 7(6):2629-2640. PubMed ID: 29733540
[TBL] [Abstract][Full Text] [Related]
18. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J
BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131
[TBL] [Abstract][Full Text] [Related]
19. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma.
Bronte F; Bronte G; Fanale D; Caruso S; Bronte E; Bavetta MG; Fiorentino E; Rolfo C; Bazan V; Di Marco V; Russo A
Crit Rev Oncol Hematol; 2016 Jan; 97():312-21. PubMed ID: 26603462
[TBL] [Abstract][Full Text] [Related]
20. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
